Thomas McFarlane
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Head and Neck Cancer Studies
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Advanced Breast Cancer Therapies 2
- Prostate Cancer Treatment and Research 1
- Oncology 5
- Colorectal Cancer Treatments and Studies 2
- PARP inhibition in cancer therapy 1
- Co-authors
- William Wong (3 shared papers)Stephen Tully (2 shared papers)Erin McKenzie (3 shared papers)Edward Chow (3 shared papers)John J. Kim (1 shared paper)Yasmeen Razvi (3 shared papers)Carlo DeAngelis (3 shared papers)Pearl Zaki (2 shared papers)
- Journals
- Supportive Care in Cancer (5 papers)The Oncologist (2 papers)PharmacoEconomics (1 paper)Medical Decision Making (1 paper)Annals of Palliative Medicine (1 paper)
- Partner nations
- CanadaUnited StatesSweden
In The Last Decade
Thomas McFarlane
17 papers receiving 286 citations
Peers
Comparison fields: 5 of 67
- Hepatology 40
- Otorhinolaryngology 11
- Surgery 100
- Oncology 60
- Family Practice 2
Countries citing papers authored by Thomas McFarlane
This map shows the geographic impact of Thomas McFarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas McFarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas McFarlane more than expected).
Fields of papers citing papers by Thomas McFarlane
This network shows the impact of papers produced by Thomas McFarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas McFarlane. The network helps show where Thomas McFarlane may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas McFarlane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 113 | |
| 2 | 2019 | 55 | |
| 3 | 2017 | 35 | |
| 4 | 2019 | 17 | |
| 5 | 2020 | 11 | |
| 6 | 2018 | 10 | |
| 7 | 2019 | 9 | |
| 8 | 2019 | 9 | |
| 9 | 2021 | 5 | |
| 10 | 2024 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2019 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 0 |
About Thomas McFarlane
Thomas McFarlane is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Dermatology, having authored 18 papers that have together received 289 indexed citations. Recurring topics across this work include Nausea and vomiting management (4 papers), Lung Cancer Treatments and Mutations (3 papers), Advanced Breast Cancer Therapies (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), PARP inhibition in cancer therapy (1 paper), Prostate Cancer Treatment and Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hepatology (40 citations), Otorhinolaryngology (11 citations), Surgery (100 citations), Oncology (60 citations) and Family Practice (2 citations). Thomas McFarlane has collaborated with scholars based in Canada, United States and Sweden. Frequent co-authors include William Wong, Stephen Tully, Erin McKenzie, Edward Chow, John J. Kim, Yasmeen Razvi, Carlo DeAngelis, Pearl Zaki, Stephanie Chan and Katarzyna J. Jerzak. Their work appears in journals such as Supportive Care in Cancer, The Oncologist, PharmacoEconomics, Medical Decision Making and Annals of Palliative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.